Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
about
Increased Hydration Can Be Associated with Weight LossEndothelial Plasticity: Shifting Phenotypes through Force FeedbackThe Role of Mitochondrial DNA in Mediating Alveolar Epithelial Cell Apoptosis and Pulmonary FibrosisAngiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life SpanSo! What's aging? Is cardiovascular aging a disease?Nitro-Arachidonic Acid Prevents Angiotensin II-Induced Mitochondrial Dysfunction in a Cell Line of Kidney Proximal Tubular CellsEffects of acute stress on cardiac endocannabinoids, lipogenesis, and inflammation in rats.The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration.Diabetes and cardiovascular disease in older adults: current status and future directions.Effects of exercise training on mitochondrial function in patients with type 2 diabetes.Vascular and metabolic dysfunction in Alzheimer's disease: a review.Estrogen and mitochondria function in cardiorenal metabolic syndrome.Cardiac steatosis potentiates angiotensin II effects in the heart.Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosisAerobic exercise reverses arterial inflammation with aging in mice.The role of sirtuins in modulating redox stressorsAging, Angiotensin system and dopaminergic degeneration in the substantia nigra.Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease.Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with agingRenal dopamine and angiotensin II receptor signaling in age-related hypertension.Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's diseaseUpregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.Late-life enalapril administration induces nitric oxide-dependent and independent metabolic adaptations in the rat skeletal muscle.Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity.Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease.A role for mitochondrial oxidants in stress-induced premature senescence of human vascular smooth muscle cells.Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney.Cardiac Hegemony of Senescence.The AGT Gene M235T Polymorphism and Response of Power-Related Variables to Aerobic Training.Kidney aging--inevitable or preventable?Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitorsBrain renin-angiotensin system in the nexus of hypertension and agingKlotho and chronic kidney disease.Oxidative stress in aging--matters of the heart and mind.The importance of klotho in phosphate metabolism and kidney disease.The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.Hypertension and insulin resistance: implications of mitochondrial dysfunction.The use of angiotensin II receptor antagonists to increase the efficacy of radiotherapy in cancer treatment.Renin-angiotensin system: an old player with novel functions in skeletal muscle.
P2860
Q26744779-DAEAAFBE-5787-4C2B-9ABF-084C760BFF82Q26767430-ADDE43E9-7538-4C8E-B910-7986C0A71DCAQ26786969-907D9D0D-914B-45E4-A459-10EB80E69773Q27309126-6715C179-B320-443E-BFE0-725DB85B7230Q28084852-9EC3839C-00AC-46D2-9A11-3D117F06A2F2Q28550560-96C9959F-4D0B-416F-9F73-811082078E58Q30422093-CC2DBD99-85EC-433E-8444-D2D828543527Q30426517-5E213D7C-A200-46BD-9473-154F98F80459Q33627982-C4091AE9-5EEA-4966-A11E-EAB122350EB7Q33959789-47CBD534-4BCD-49EA-A771-56F5824D109DQ34023559-EA7F99EF-FB15-40E3-8118-983284D8FF31Q34193337-23D53A4F-C9F9-4F0D-96A0-6A5DB0B6DFB1Q35054122-920A7AA6-DBF4-4876-B6C1-BC1F7EC4C86FQ35086438-1478D46B-2003-437C-A876-EC5C10A13F48Q35114963-3E07A55D-A7BD-46EA-BD22-1B6DD0F90785Q35314627-76571AE9-BA7F-459D-85D3-783963937A2CQ35658838-5118D9B3-B82C-4AD0-87DD-EE79B232A978Q35806742-73F6A3A8-0979-436D-A0CD-EA13BD2D2EDAQ35819219-452F836D-CF36-41E9-A71F-E23AEC7A30ADQ36485537-8C0C516D-CEC2-4B5E-B2DD-2508E29CACF3Q36527864-254E702D-6D53-4390-9EF8-32739461DBBAQ36576487-E4A525AE-85F7-4209-A964-08147BF4E091Q36974726-C57F7617-E1BF-4145-8AE8-F7C45DF14175Q36993333-BF12B4A1-5BB3-4C84-8AF3-4A58E21AE781Q37003151-18BAFC5F-0B84-4C72-A961-F8EF96F0FB9EQ37166958-96442C88-5E10-4260-B6CC-2A43379CC029Q37272651-B827130E-4C16-4A56-8008-964FE13577A9Q37324997-ED4DC2EB-C76E-4B2E-AEA9-331CDBA47302Q37390192-2A7FFFD1-9280-46AF-8732-71B6E17EA195Q37459694-6363D674-76A6-4EB9-9AB5-EE75E51125EEQ37913979-C57EC327-B708-413A-9D44-3BF0DE9AFC00Q37962590-599ECF21-A044-49A8-997F-730637BC2D8BQ38053075-5AFA40FE-55F5-4C27-B39C-F58DC4A90A8CQ38104935-C778588B-1B24-4930-B8CE-B5D75BF393C4Q38133938-9044F30F-5295-4828-8223-793D6B3E7916Q38205938-6DF7A502-EE41-498E-8598-3167FA7C421DQ38224257-AD5006AF-0608-4E84-A19A-F0B5345CBB09Q38272560-3DAF13DF-930F-418D-8D02-6B1C19FC600AQ38294600-6D887D79-462B-4FD9-B6A7-1766C97A4847Q38375202-DA7C60D3-7551-4662-A088-FEEA96CA2363
P2860
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@en
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@nl
type
label
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@en
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@nl
prefLabel
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@en
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@nl
P2093
P2860
P356
P1476
Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?
@en
P2093
Elena M V de Cavanagh
Felipe Inserra
León Ferder
P2860
P356
10.1093/CVR/CVQ285
P577
2010-09-06T00:00:00Z